 |
 |
 |
|
Safety and Efficacy of Doravirine in Treatment-Naïve Adults with HIV-1: 4 Years of Experience From the DRIVE-FORWARD and DRVIVE-AHEAD Clinical Trials
|
|
|
18th EACS 2021 Oct 27-30 virtual & London, UK
Jean-Michel Molina,1 Chloe Orkin,2 Pedro Cahn,3 Johannes Lombaard,4 Khuanchai Supparatpinyo,5 Havilland Campbell,6 Hong Wan,6 Valerie Teal,6 Jin Xu,6 Ernest Asante-Appiah,6 Peter Sklar,6 Hedy Teppler,6 Rima Lahoulou7
1University of Paris, Hôpital Saint Louis APHP, Paris, France; 2Queen Mary University of London, London, United Kingdom; 3Fundación Huésped, Buenos Aires, Argentina; 4Josha Research, Bloemfontein, South Africa; 5Chiang Mai University, Chiang Mai, Thailand; 6Merck & Co. Inc., Kenilworth, NJ, USA; 7MSD France, Puteaux, France





|
|
|
 |
 |
|
|